Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Endocrinol.

Sec. Clinical Diabetes

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1611540

Efficacy of an Advanced Hybrid Closed-Loop System in a Patient with Type 1 Diabetes and Intellectual Disability: A Case Report

Provisionally accepted
Keiji  SugaiKeiji Sugai*Hidetsugu  TakaHidetsugu TakaJumpei  ShikumaJumpei ShikumaRyo  SuzukiRyo Suzuki
  • Tokyo Medical University, Tokyo, Japan

The final, formatted version of the article will be published soon.

Recent advances in automated insulin delivery (AID) system have been remarkable. The advanced hybrid closed-loop (AHCL) system made it easier to achieve optimal glycemic targets. According to previous studies, the AHCL system achieves relatively good glycemic control without strict carbohydrate input.These studies suggested that AID systems potentially improve glycemic control among patients with difficulty with self-management. However, few studies have focused on the efficacy of the systems among these patients. We present a case of a 30-year-old woman with type 1 diabetes and intellectual disabilities (full-scale intelligence quotient = 67) due to Shwachman-Diamond syndrome. While using a sensoraugmented pump with the predictive low glucose suspend system, her glycated hemoglobin levels consistently ranged from 9.0% to 10.0%, and she experienced frequent hospitalizations due to diabetic ketoacidosis. Stepping up to a hybrid closed-loop system achieved better glycemic control and prevented hospitalizations due to diabetic ketoacidosis. Finally, the patient achieved optimal glycemic control through the use of the AHCL system. Our case highlights the potential of AID systems in patients with type 1 diabetes and self-management difficulties, including those with intellectual disabilities.

Keywords: type 1 diabetes mellitus, Intellectual Disability, insulin pump therapy, Schwachmann-Diamond syndrome (SDS), AHCL system, self-management

Received: 14 Apr 2025; Accepted: 16 Jul 2025.

Copyright: © 2025 Sugai, Taka, Shikuma and Suzuki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Keiji Sugai, Tokyo Medical University, Tokyo, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.